Paediatric Consumer Health in France

Paediatric Consumer Health in France

In 2024, the paediatric consumer health in France is experiencing difficulties regarding OTC sales. The diminishing effects of the COVID-19 pandemic are becoming increasingly apparent, as children are now interacting with each other more frequently. The lifting of restrictions, including the requirement to wear masks, has resulted in a higher susceptibility to infections among children. In early 2023, France faced a “triple epidemic,” comprising bronchiolitis, influenza, and, to a lesser extent,...

Euromonitor International's Paediatric Consumer Health in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.